Strategies for Optimal HIV Treatment and Prevention

In this comprehensive online program led by expert faculty learn about implementation of rapid ART in newly diagnosed people with HIV choosing an individualized first-line regimen for each patient factors to consider when modifying therapy in virologically suppressed individuals or in patients with virologic failure and evaluating patients for PrEP. Watch the Medical Minute videos and have your questions answered by faculty during the live webinars. Download the slides and patient education resources listen to podcasts and read the companion ClinicalThought commentaries.

Activities

利用技术优化 PrEP 的依从性和持久性

Slideset Download

Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2023

Expires: February 22, 2024

View Activity

Switch Strategies

Activities

A Patient’s Perspective: Switching From Oral Therapy to Long-Acting Injectable ART

Clinical Thought

Released: August 30, 2022

Expires: August 29, 2023

View Activity

A Patient’s Perspective: Managing Weight Gain on ART My Way

Clinical Thought

Released: September 08, 2022

Expires: September 07, 2023

View Activity

Strategies for Optimal HIV Treatment and Prevention: Considering a Switch to Long-Acting ART

Slideset Download

Released: September 16, 2022

Expires: September 15, 2023

View Activity

Principles for Switching Antiretroviral Therapy: Determinants of ART Choice

Clinical Thought

Released: October 11, 2022

Expires: October 10, 2023

View Activity

Answering the Questions on Switching ART With Virologic Suppression

Podcast Episodes

Released: October 19, 2022

Expires: October 18, 2023

View Activity

Strategies for Optimal HIV Treatment and Prevention: Considering Bictegravir in Pregnancy

Slideset Download

Released: October 20, 2022

Expires: October 19, 2023

View Activity

Strategies for Optimal HIV Treatment and Prevention: Considering an ART Switch After Weight Gain

Slideset Download

Released: October 21, 2022

Expires: October 20, 2023

View Activity

Strategies for Optimal HIV Treatment and Prevention: Considering Cabotegravir in Pregnancy

Slideset Download

Released: October 21, 2022

Expires: October 20, 2023

View Activity

Studies on Newer Antiretrovirals in Pregnancy: Time for a Paradigm Shift

Clinical Thought

Released: November 02, 2022

Expires: November 01, 2023

View Activity

Audio Recap: Switching HIV ART in Pregnancy

Answering the Questions on Considering an ART Switch During Pregnancy

Podcast Episodes

Released: December 19, 2022

Expires: December 18, 2023

View Activity

Doing More With Less: Moving Toward Intermittent ART Dosing Strategies for Extended Virologic Suppression in France

Clinical Thought

Released: January 04, 2023

Expires: January 03, 2024

View Activity

My Perspective on the New US Infant Feeding Recommendations for People With HIV

Clinical Thought

Released: April 06, 2023

View Activity

Why I Recommend Drug Resistance Testing Prior to Long-Acting Injectable ART Initiation

Clinical Thought

Released: July 18, 2023

View Activity

Coinfections

Activities

Strategies for Optimal HIV Treatment and Prevention: Monkeypox in PWH

Slideset Download

Released: November 07, 2022

Expires: November 06, 2023

View Activity

Answering the Questions on Monkeypox in PWH

Podcast Episodes

Released: December 19, 2022

Expires: December 18, 2023

View Activity

Prevention

Activities

A Patient’s Perspective: Factors Influencing My PrEP Persistence

Clinical Thought

Released: January 04, 2023

Expires: January 03, 2024

View Activity

Minuto médico: idoneidad de la PrEP en curso

Consideraciones acerca de idoneidad de la PrEP en curso

Slideset Download

Released: February 21, 2023

Expires: February 20, 2024

View Activity

考虑持续的 PrEP 的候选资格

Slideset Download

Released: February 21, 2023

Expires: February 20, 2024

View Activity

Considering Ongoing PrEP Candidacy

Slideset Download

Released: February 24, 2023

Expires: February 23, 2024

View Activity

Personalizing My PrEP: A Patient’s Perspective

Clinical Thought

Released: February 28, 2023

Expires: February 27, 2024

View Activity

Minuto Médico: Eventual Adequação da Aplicação Continuada de uma Terapia PrEP

Considerar a Candidatura Contínua à Terapia PrEP

Slideset

Released: February 28, 2023

Expires: February 27, 2024

View Activity

Minuto Médico: Otimizar a Aderência da Terapia PrEP Usando as Novas Tecnologias

Otimizar a Aderência e a Manutenção da Terapia PrEP Usando as Novas Tecnologias

Slideset

Released: February 28, 2023

Expires: February 27, 2024

View Activity

Optimizing PrEP Adherence and Persistence With Technology

Slideset Download

Released: February 28, 2023

Expires: February 27, 2024

View Activity

Answering the Questions on PrEP Persistence

Video

Released: March 07, 2023

View Activity

Minuto médico: Optimización de la PrEP por medio de la tecnología

Optimización del cumplimiento y la persistencia de la PrEP por medio de la tecnología

Slideset

Released: March 13, 2023

Expires: March 11, 2024

View Activity

Answering the Questions on HIV PrEP Persistence

Podcast Episodes

Released: March 16, 2023

Expires: March 14, 2024

View Activity

The Importance of Understanding Unique Patient Needs to Promote PrEP Persistence

Clinical Thought

Released: March 22, 2023

View Activity

关于通过技术优化 PrEP 依从性和持久性的评论

Clinical Thought

Released: May 05, 2023

View Activity

关于 PrEP 功效和安全性的评论

Clinical Thought

Released: May 05, 2023

View Activity

Improving HIV Prevention in Latin American Countries

Clinical Thought

Released: May 18, 2023

View Activity

Choosing On-Demand PrEP: A Patient’s Perspective

Clinical Thought

Released: June 06, 2023

View Activity

Evaluating People for PEP and PrEP

Video

Released: June 09, 2023

View Activity

Choosing Among PrEP Options

Video

Released: June 09, 2023

View Activity

Evaluating People for PEP and PrEP

Slideset

Released: June 12, 2023

View Activity

Answering the Questions on PrEP Initiation

Video

Released: July 19, 2023

View Activity

Initial Therapy

Activities

Rapid Initiation of ART After HIV Seroconversion on LA PrEP

Video

Released: March 23, 2023

View Activity

Medical Minute: Rapid ART With Psychosocial Dynamics

Rapid ART Initiation and Complex Psychosocial Dynamics

Video

Released: March 23, 2023

View Activity

Rapid ART Initiation and Complex Psychosocial Dynamics

Slideset

Released: March 24, 2023

View Activity

Rapid Initiation of ART After HIV Seroconversion on LA PrEP

Slideset

Released: March 29, 2023

View Activity

Answering the Questions on Rapid ART Initiation

Video

Released: April 10, 2023

View Activity

Diapositivas: TAR rápido con dinámicas psicosociales

Iniciación rápida del TAR y dinámicas psicosociales complejas

Slideset Download

Released: April 10, 2023

View Activity

Slides: Iniciação Rápida de TARV e Dinâmica Psicossocial

Iniciação Rápida de TARV e Dinâmica Psicossocial Complexa

Slideset Download

Released: April 10, 2023

View Activity

快速抗逆转录病毒疗法 (ART) 和复杂的心理社会动力学

Slideset

Released: April 13, 2023

View Activity

Rapid ART Initiation: Answering the Questions

Podcast Episodes

Released: April 19, 2023

View Activity

Choosing Among Initial ART Options for an Older PWH With Cardiometabolic Risk Factors

Video

Released: May 12, 2023

View Activity

Medical Minute: Initial ART for PWH of Childbearing Potential

Choosing Between Initial ART Options for a Woman of Childbearing Potential

Video

Released: May 18, 2023

View Activity

Slides: Initial ART With CV Risk Factors

Choosing Among Initial ART Options for an Older PWH With Cardiometabolic Risk Factors

Slideset

Released: May 19, 2023

View Activity

尽快启动抗病毒治疗和复杂的心理社会动力学-Clinical Options

Clinical Thought

Released: May 25, 2023

View Activity

Answering the Questions on Choosing Between Initial ART Options

Video

Released: May 30, 2023

View Activity

Escolher as opções iniciais de TARV para uma pessoa idosa com fatores de risco cardiometabólicos

Slideset

Released: May 30, 2023

View Activity

为具有心脏代谢风险因素的老年 PWH 选择初始 ART 方案

Slideset

Released: May 30, 2023

View Activity

Diapositivas: ART inicial con factores de riesgo CV

Elección de entre las opciones iniciales de TAR para PCV de edad avanzada con factores de riesgo cardiometabólicos

Slideset

Released: May 30, 2023

View Activity

Choosing Between Initial ART Options: Answering the Questions

Podcast Episodes

Released: June 06, 2023

View Activity

Slides: Initial ART With Childbearing Potential

Choosing Between Initial ART Options for a Woman of Childbearing Potential

Slideset

Released: June 08, 2023

View Activity

关注老年HIV感染者的心血管病管理，合理使用ART方案

Clinical Thought

Released: July 11, 2023

View Activity

PrEP Initiation: Answering the Questions

Podcast Episodes

Released: July 13, 2023

View Activity

Downloadable Resources for Patients

Activities

Patient Education: Supporting HIV Medication Taking

Patient Education PDF on Supporting HIV Medication Taking

PDF

Released: July 11, 2023

View Activity

Patient Education PDF on HIV Prevention with PrEP and PEP

PDF

Released: July 12, 2023

View Activity

Patient Education on Switching ART

PDF

Released: July 20, 2023

View Activity

Strategies for Patients With Treatment Experience

Activities

Considerations After First-line INSTI Failure

Video

Released: June 22, 2023

View Activity

Understanding HIV Virologic Blips

Clinical Thought

Released: June 23, 2023

View Activity

Managing Low-level Viremia in People Living With HIV

Video

Released: June 27, 2023

View Activity

Managing Low-level Viremia in People Living With HIV

Slideset

Released: June 30, 2023

View Activity

Considerations After First-line INSTI Failure

Slideset

Released: July 03, 2023

View Activity

Considering Novel Mechanism ART for Overcoming Resistance

Video

Released: July 10, 2023

Expires: July 09, 2024

View Activity

Considering Novel Mechanism ART for Overcoming Resistance

Slideset

Released: July 10, 2023

View Activity

Strategies for Patients With Treatment Experience

Video

Released: July 24, 2023

View Activity

Managing ART Failure: Answering the Questions

Podcast Episodes

Released: August 03, 2023

View Activity

Faculty

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

Amanda Binkley, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Penn Presbyterian Medical Center
Pennsylvania, Philadelphia

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, United Kingdom

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana

Michelle Cespedes, MD, MS

Professor of Medicine
Division of Infectious Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Meredith E. Clement, MD

Associate Professor of Medicine
Section of Infectious Diseases
Louisiana State University Health Sciences Center-New Orleans
New Orleans, Louisiana

Brenda E. Crabtree Ramírez, MD

Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Emily Drwiega, PharmD, BCIDP, BCPS, AAHIVP

Visiting Clinical Assistant Professor of Pharmacy Practice
Department of Pharmacy Practice, Infectious Disease Section
University of Illinois at Chicago, College of Pharmacy
Chicago, Illinois

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Annette Haberl, MD

Physician
Head of HIV and Women, HIVCENTER Frankfurt
Department of Infectious Diseases
Hospital of the Johann Wolfgang Goethe-University
Frankfurt, Germany

Robin Hardwicke, PhD, FNP-C, AACRN, FAAN

Professor
General Internal Medicine & Obsterics/Gynecology
McGovern Medical School- The University of Texas Health Science Center Houston
Nurse Practitioner
General Internal Medicine
UT Physicians
Houston, Texas

Jenna Januszka, PharmD, BCPS, AAHIVP

PGY2 HIV/Infectious Disease Pharmacy Resident
Department of Pharmacy Practice
University of Illinois, Chicago College of Pharmacy
Chicago, Illinois

Wu Jie, PhD ( 吴杰，博士 )

吴杰，博士
传染病诊治国家重点实验室
国家临床研究中心（传染病）
感染性疾病诊治协同创新中心
浙江大学医学院附属第一医院

Christine Katlama, MD

Professor
Sorbonne University APHP Paris
Head, HIV/Hepatitis Clinical and Research Unit
Department of Infectious Diseases
Paris, France

Daniel R Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Guodong Mi, MD, PhD

中国预防性病艾滋病基金会

Cristina Mussini, MD

Full Professor of Infectious Diseases
Division of Infectious Diseases
University of Modena and Reggio Emilia
Modena, Italy

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Anonymous Patient

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Darrell H S Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St Michael's Hospital
Toronto, Ontario, Canada

Kenric Ware, PharmD, MBA, AAHIVP

Clinical Associate Professor
Department of Pharmacy Practice
Mercer University College of Pharmacy
Atlanta, GA

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Yan Zhao, MD, PhD

Professor of Public Health
Director of Division of Treatment and Care
National Center for AIDS/STD Control and Prevention
China CDC
Beijing, China

Provided by

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Clinical Education Alliance Terms and Conditions

These Terms of Use ("Terms") apply to your use of the websites, mobile applications and other resources provided by Clinical Education Alliance LLC (“CEA”) and its affiliates (referred to collectively as "CEA," "us," "we" and "our") that are intended for use by healthcare professionals, which we refer to as the "CEA Network," including the personalized information and services that meet the needs and interests of users of the CEA Network such as medical news, reference content, clinical tools, applications, sponsored programs, advertising, email communications, continuing medical education, market research opportunities and discussion forums (collectively, the "Services"). You will always be able to view the most current version of these Terms by clicking on the Terms of Use link at the bottom of any page of a CEA Network property. Note that these Terms do not apply to our properties and services that display a link to different terms of use. In the event that we expand the CEA Network through our acquisition of another company and/or its properties, that company may operate its properties subject to its own terms of use accessible via a link on such properties until we integrate its practices with ours, at which point a link to these Terms will be displayed on its properties. By using the Services, you agree to these Terms, whether or not you are a registered member of the CEA Network. These Terms govern your use of the Services and create a binding legal agreement that we may enforce against you in the event of a violation. If you do not agree to all of these Terms of Use, do not use the Services!

We reserve the right to change these terms from time to time. The most current version may be viewed by clicking on the “Terms of Use” link at the bottom of designated pages on the Clinical Education Alliance Sites. Use of the Clinical Education Alliance Sites after the effective date constitutes acceptance of the amended Terms of Use. When you leave a CEA Web site and go to another Web site, different terms apply and CEA has no responsibility or liability for any content on those sites.

Clinical Education Alliance Content

The Clinical Education Alliance Sites incorporate information, including modules, capsules, journal articles, medical news, references, interactive case studies, other continuing education material, downloadable software applications, advertising, and other healthcare information, which is intended for adults who are licensed healthcare professionals. This information is not intended to serve as a substitute for the healthcare professional’s clinical judgment. If you are a consumer who chooses to read this professional-level information on Clinical Education Alliance Sites, you should not use or rely on that information as professional medical advice or use it to replace any relationship with your physician or other qualified healthcare professional or any information they may have provided to you. For medical issues or concerns, including decisions about medications and other treatments, consumers should always consult their physician or, in serious cases, seek immediate assistance from emergency personnel.

The Content on the Clinical Education Alliance Sites is developed or selected in accordance with our published Editorial Policies. However, users access and use this material at their own risk. It is the reader’s job to evaluate the accuracy of any information and results from interactive programs found on the Clinical Education Alliance Site. If you are a healthcare professional, you should rely on your professional judgment in evaluating any and all information and confirm the information contained on the Clinical Education Alliance Sites with other sources and reliable third parties before basing any treatment or advice on it. If you are a consumer, you should evaluate the information together with your physician or another qualified healthcare professional.

DISCLAIMERS AND LIMITATIONS OF LIABILITY

THE CONTENT, APPLICATIONS, SOFTWARE, AND ALL OTHER MATERIAL ON THE CLINICAL EDUCATION ALLIANCE SITES ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. ALL WARRANTIES, EXPRESS OR IMPLIED, ARE HEREBY DISCLAIMED. CLINICAL EDUCATION ALLIANCE SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, PHYSICAL HARM OR INJURIES, LOST REVENUES, OR LOST PROFITS, RESULTING FROM THE USE OR MISUSE OF THE CLINICAL EDUCATION ALLIANCE SITES, OR ANY INFORMATION, APPLICATIONS, MATERIALS, OR SOFTWARE THEREON, EVEN IF CLINICAL EDUCATION ALLIANCE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR FOR ANY CLAIM BY ANOTHER PARTY. CLINICAL EDUCATION ALLIANCE DOES NOT WARRANT THAT THIS SITE OR ANY APPLICATIONS OR SOFTWARE WILL BE FREE OF BUGS, INACCURACIES, OR ERRORS, NOR DOES CLINICAL EDUCATION ALLIANCE WARRANT THAT ANY SITE, SOFTWARE, OR APPLICATION IS FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS.

A user’s use of the Clinical Education Alliance Sites, and any reliance on any materials, information, software, or applications, is at the user’s own risk. You agree that you hereby release Clinical Education Alliance and its affiliates, owners, respective directors, officers, employees, advertisers, authors, and contributors from any and all liability or obligations arising from the use of the Clinical Education Alliance Sites. A user’s sole remedy for any problem or concern is to exit the Web site or application. You agree that you will indemnify and hold Clinical Education Alliance harmless for any loss, damages, or liability suffered by Clinical Education Alliance as a result of your use of any Clinical Education Alliance Site or material, application, information, or software thereon or your submission of any material to Clinical Education Alliance. Clinical Education Alliance reserves the right to restrict or limit access to this Web site.

CEA Programs, Tools, and Databases

The Clinical Education Alliance Sites include interactive programs, clinical tools, and databases intended for the use of healthcare professionals. These materials are not intended as professional advice or recommendations of particular products. Physicians and other healthcare professionals who use our interactive programs, tools, or databases should exercise their own clinical judgment as to the results. Consumers who use the tools or databases do so at their own risk.

Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns or issues, including decisions about medications and other treatments, users should always consult their physician or other qualified healthcare professional.

Ownership of Clinical Education Alliance Sites—Copyright and Trademarks

The entire contents and design of the Clinical Education Alliance Sites, including the software applications, tools, and databases, are protected under US and international copyright laws. These materials are owned by CEA or its affiliates or are used with permission of their owners or as otherwise authorized by law. All rights are reserved, worldwide. You may look at the Clinical Education Alliance Sites, download individual articles or applications to your personal computer or handheld device, and print a reasonable number of pages for your own personal reference. You must not remove any copyright notices from our materials. We reserve all our other rights. This means you may not sell, rewrite, or modify any content or other material found on any Clinical Education Alliance Site, redistribute it, put it on your own Web site, or use it for any commercial purpose without our prior written authorization.

The names of the CEA products and services are protected by trademark laws in the United States. Any use of our trademarks or service marks requires prior written approval from CEA.

You may link to a CEA Web site if your Web site offers products, services, or information of interest to the professional healthcare community. You are not allowed to link to the Clinical Education Alliance Sites if you post illegal, obscene, or offensive content or if the link is likely to have a negative impact on CEA’s reputation. Any other use, such as framing any part of a CEA Web site or incorporating any CEA content into another Web site, product, or application, requires advance written permission from Clinical Education Alliance. Clinical Education Alliance assumes no responsibility for any Web sites or materials that are linked to Clinical Education Alliance Sites or materials.

Software Products and Applications

Clinical Education Alliance makes some software and accompanying documentation available for downloading from our Web sites and/or from iTunes. These materials are protected by copyrights under US and international law and are owned by Clinical Education Alliance or companies that have licensed the software to us. We do not transfer any ownership rights in software or documentation to you when you download it from our Web site and/or directly from iTunes. You may use the software and accompanying documentation for their intended purpose. You are not authorized to further copy or distribute the software and accompanying documentation, nor may you attempt to recreate or reverse engineer our software or applications. In addition, some software available for downloading from our Web sites and/or from iTunes is subject to US export controls. By downloading or using such software, you are representing to us that your download of such software complies with these controls.

US Government End Users

If you are affiliated with the US government, please note that the software and documentation available on our Web sites and/or directly from iTunes are “commercial items,” as that term is defined in 48 C.F.R. 2.101 (October 1995), consisting of “commercial computer software” and “commercial computer software documentation,” as such terms are used in 48 C.F.R. 12.212 (September 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1 through 227.7202-4 (June 1995), all US government end users acquire the software and documentation with only those rights set forth herein.

Social Media, Message Boards, and Forums

Clinical Education Alliance offers users the opportunity to engage in social media interactions with both experts and other users of the sites. As with other online social media, users must exercise sound judgment in both the information that they post and in how they assess the postings of other users. As such, users are expected to adhere to the social media recommendations made by the American Medical Association when utilizing the social media capabilities of CEA sites. In particular, users must be cognizant of standards of patient privacy and confidentiality that must be maintained in all environments and must not post identifiable patient information on CEA sites. In social media interactions, users must maintain appropriate boundaries of the patient–physician/care provider relationship in accordance with professional ethical guidelines just as they would in any other context. Users acknowledge that privacy settings are not absolute and that once on the Internet, content posted by them may be copied by third parties and republished out of the control of Clinical Education Alliance. Thus, users should routinely monitor their own Internet presence to ensure that the personal information and content that they post and, to the extent possible, that is posted about them by others is accurate and appropriate.

Users are expected to refrain from submitting comments or messages that are defamatory, hateful, or obscene or that harass others. Users may not impersonate any other person or violate any other person’s or entity’s legal rights or submit falsified credentials or experiences. Users agree that they will not submit any materials that violate or infringe any copyrights, trademarks, patents, trade secret, or other intellectual property rights of any third party. Clinical Education Alliance retains all copyrights in the content posted by users to its sites. Clinical Education Alliance may adopt additional rules to govern use of social media, message boards or forums, to which users will be subject.

Copyright and Other Legal Violations

If you believe that any material on this Web site infringes your copyright, please notify us as follows, under the Digital Millennium Copyright Act (“DMCA”). To notify us, the DMCA requires that you: 1. Send an email notice to Clinical Education Alliance at customersupport@clinicaloptions.com. 2. Include the following information in your email: a. Identify the copyrighted work(s) you claim is infringed; b. Identify the material you claim is infringing the copyright(s) and give enough information for Clinical Education Alliance to locate that material; c. Include a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf (the “Claimant”); d. Include the Claimant’s name, address, and telephone number(s); e. Include a statement that the Claimant has a good faith belief that use of the disputed material is not authorized by the copyright owner or his agent; and f. Include a statement, under penalty of perjury, that the information in the notification of copyright infringement is accurate and that the Claimant is the copyright owner or is authorized to act on behalf of the copyright owner.

If you believe any content or material on the Clinical Education Alliance Sites violates any laws, please notify customersupport@clinicaloptions.com. Please include details about your concerns and an email address for contacting you.

Governing Law

Clinical Education Alliance controls the Clinical Education Alliance Sites from its offices in the state of Virginia in the United States of America. The Clinical Education Alliance Sites can be accessed from any of the United States and from other countries worldwide. Since the laws of each state or country may differ, both you and Clinical Education Alliance agree that the laws of Virginia, without regard to conflicts of laws principles, will apply to all matters relating to use of the Clinical Education Alliance Sites and materials, including software and applications.

Clinical Education Alliance makes no representation that materials on these sites are appropriate or available for use in countries aside from the United States. Accessing the Clinical Education Alliance Sites from territories where their contents are illegal is prohibited. Those who choose to access these sites from other locations do so at their own risk and are responsible for compliance with any and all applicable local laws or regulations.

Acceptance Procedure

By downloading or accessing materials on the Clinical Education Alliance Sites and/or directly from iTunes or registering with us, you agree to all the terms and conditions in this agreement, including the Terms of Use and Privacy Policy. If you disagree with any of these Terms of Use or Privacy Policy, please refrain from using the Clinical Education Alliance Sites or materials.

Privacy Policy

Because we provide education for healthcare professionals, we pay special attention to privacy issues. The purpose of our Privacy Policy is to identify the information we may collect about you, describe the uses we may make of your information and the security measures we take to protect it, and discuss your options for controlling your information. You can review our Privacy Policy by clicking on the “Privacy Policy” link at the bottom of designated pages on the Clinical Education Alliance Sites.

Disputes

If you fail to comply with these terms, we have the right to suspend or eliminate your account and remove any information you have placed on our site, including your registration information. We may also take any legal action we think is appropriate. If there is any dispute between us concerning this agreement or your use of any Clinical Education Alliance Site or materials or applications, we both agree to submit the dispute to nonbinding mediation, followed by binding arbitration. Both the mediation and the arbitration will be governed under the rules of the American Arbitration Association, and the venue for the arbitration will be Virginia.

Questions or Concerns About Our Terms of Use

For questions or concerns about these Terms of Use, please send an email to customersupport@clinicaloptions.com

These terms of use were last updated in July 2021.